Articles from Khondrion B.V.

Khondrion Announces First Patient Dosed in Phase II Study Targeting Debilitating Post-COVID Fatigue
SON4PEM trial advances development of sonlicromanol, aiming to address chronic fatigue in Post-COVID patients with post-exertional malaise
By Khondrion B.V. · Via GlobeNewswire · May 19, 2026